Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC) Meeting Abstract
| Authors: | Song, X.; Kelley, R. K.; Khan, A.; Standifer, N.; Krishna, R.; Liu, L.; Wang, K.; Green, M.; McCoon, P.; Negro, A.; He, P.; Narwal, R.; Abou-Alfa, G. K. |
| Abstract Title: | Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC) |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800330 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.313 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 313 -- Source: Wos |
